Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.

Matthias MollŁukasz MagrowskiMartina MittlböckHarald HeinzlChristian KirisitsJakub CiepałOliwia MasriGerd HeilemannRafał StandoTomasz KrzysztofiakGabriela DepowskaAndrea d'AmicoTomasz TechmańskiAnna KozubWojciech MajewskiRafał SuwińskiPiotr WojcieszekJacek SadowskiJoachim WidderGregor GoldnerMarcin Miszczyk

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)

offered a BC advantage compared with dose-escalated EBRT and lower BTB doses.

Keyphrases

prostate cancer
high dose
radical prostatectomy
radiation therapy
locally advanced
low dose
squamous cell carcinoma